These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 9282935)

  • 1. Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum.
    Cadogan AK; Alexander SP; Boyd EA; Kendall DA
    J Neurochem; 1997 Sep; 69(3):1131-7. PubMed ID: 9282935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examination of the effect of the cannabinoid receptor agonist, CP 55,940, on electrically evoked transmitter release from rat brain slices.
    Gifford AN; Samiian L; Gatley SJ; Ashby CR
    Eur J Pharmacol; 1997 Apr; 324(2-3):187-92. PubMed ID: 9145770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain.
    Kathmann M; Bauer U; Schlicker E; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):466-70. PubMed ID: 10431757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes.
    Sagan S; Venance L; Torrens Y; Cordier J; Glowinski J; Giaume C
    Eur J Neurosci; 1999 Feb; 11(2):691-9. PubMed ID: 10051770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis.
    Köfalvi A; Rodrigues RJ; Ledent C; Mackie K; Vizi ES; Cunha RA; Sperlágh B
    J Neurosci; 2005 Mar; 25(11):2874-84. PubMed ID: 15772347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus.
    Schlicker E; Timm J; Zentner J; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):583-9. PubMed ID: 9402037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid CB1 receptor-mediated modulation of evoked dopamine release and of adenylyl cyclase activity in the human neocortex.
    Steffens M; Engler C; Zentner J; Feuerstein TJ
    Br J Pharmacol; 2004 Apr; 141(7):1193-203. PubMed ID: 14993102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor.
    Calandra B; Portier M; Kernéis A; Delpech M; Carillon C; Le Fur G; Ferrara P; Shire D
    Eur J Pharmacol; 1999 Jun; 374(3):445-55. PubMed ID: 10422789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors.
    Terranova JP; Michaud JC; Le Fur G; Soubrié P
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):576-9. PubMed ID: 8751088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid CB1 receptor-mediated inhibition of acetylcholine release in the brain of NMRI, CD-1 and C57BL/6J mice.
    Kathmann M; Weber B; Schlicker E
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):50-6. PubMed ID: 11191836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cannabinoids on dopamine release in the corpus striatum and the nucleus accumbens in vitro.
    Szabo B; Müller T; Koch H
    J Neurochem; 1999 Sep; 73(3):1084-9. PubMed ID: 10461898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines.
    Derocq JM; Bouaboula M; Marchand J; Rinaldi-Carmona M; Ségui M; Casellas P
    FEBS Lett; 1998 Apr; 425(3):419-25. PubMed ID: 9563506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid CB(1) receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues.
    Stamer WD; Golightly SF; Hosohata Y; Ryan EP; Porter AC; Varga E; Noecker RJ; Felder CC; Yamamura HI
    Eur J Pharmacol; 2001 Nov; 431(3):277-86. PubMed ID: 11730719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse.
    Lay L; Angus JA; Wright CE
    Eur J Pharmacol; 2000 Mar; 391(1-2):151-61. PubMed ID: 10720647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of electrically evoked acetylcholine release through cannabinoid CB1 receptors: evidence for an endocannabinoid tone in the human neocortex.
    Steffens M; Szabo B; Klar M; Rominger A; Zentner J; Feuerstein TJ
    Neuroscience; 2003; 120(2):455-65. PubMed ID: 12890515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoids inhibit sodium-dependent, high-affinity excitatory amino acid transport in cultured rat cortical astrocytes.
    Shivachar AC
    Biochem Pharmacol; 2007 Jun; 73(12):2004-11. PubMed ID: 17445778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid modulation of rat pup ultrasonic vocalizations.
    McGregor IS; Dastur FN; McLellan RA; Brown RE
    Eur J Pharmacol; 1996 Oct; 313(1-2):43-9. PubMed ID: 8905327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain.
    Burkey TH; Quock RM; Consroe P; Ehlert FJ; Hosohata Y; Roeske WR; Yamamura HI
    Eur J Pharmacol; 1997 Oct; 336(2-3):295-8. PubMed ID: 9384246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of hippocampal acetylcholine release by cannabinoids: reversal by SR 141716A.
    Gessa GL; Mascia MS; Casu MA; Carta G
    Eur J Pharmacol; 1997 May; 327(1):R1-2. PubMed ID: 9185841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist.
    Gallate JE; Saharov T; Mallet PE; McGregor IS
    Eur J Pharmacol; 1999 Apr; 370(3):233-40. PubMed ID: 10334497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.